In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China's State FDA To Start Electronically Monitoring Drugs In March

This article was originally published in PharmAsia News

Executive Summary

China's State FDA will inaugurate its national electronic drug monitoring system in March 2011, first targeting essential drugs and progressively expanding to all drugs in the country

China's State FDA will inaugurate its national electronic drug monitoring system in March 2011, first targeting essential drugs and progressively expanding to all drugs in the country.

By giving each drug a unique electronic identity, the system enables regulators to conduct monitoring throughout the process and confirm authenticity of drugs, said SFDA Deputy Commissioner Bian Zhenjia at a recent meeting on counterfeiting. Meanwhile, SFDA has begun collaboration with medical device companies on counterfeit drugs and advanced identification technology support. (Click Here For More - Chinese Language)

"Essential Drugs To Have 'Identity Documents' Next Year To Help Public Check Authenticity"- health.sohu.com (12/22/2010)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC073899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel